Eveline de Bont

1.5k total citations
11 papers, 568 citations indexed

About

Eveline de Bont is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Rheumatology. According to data from OpenAlex, Eveline de Bont has authored 11 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Rheumatology. Recurrent topics in Eveline de Bont's work include Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Eveline de Bont is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Eveline de Bont collaborates with scholars based in Netherlands, Belgium and Italy. Eveline de Bont's co-authors include Roel J. Bolt, Marcel J. I. J. Albers, W. A. Kamps, S. de Graaf, Andrea Biondi, André Baruchel, Meinolf Suttorp, Frédéric Millot, Josu de la Fuente and Marie‐Françoise Dresse and has published in prestigious journals such as Blood, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

Eveline de Bont

11 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eveline de Bont Netherlands	8	227	147	147	133	113	11	568
Reo Tanoshima Japan	13	97 0.4×	65 0.4×	125 0.9×	85 0.6×	136 1.2×	40	456
Michelle A. Roesler United States	14	148 0.7×	49 0.3×	285 1.9×	141 1.1×	217 1.9×	42	608
H. Schouten Curacao	15	372 1.6×	312 2.1×	106 0.7×	74 0.6×	116 1.0×	36	753
Anne‐Marie Langevin United States	12	95 0.4×	32 0.2×	98 0.7×	103 0.8×	154 1.4×	29	518
Antoine N. Saliba United States	15	461 2.0×	409 2.8×	47 0.3×	117 0.9×	63 0.6×	59	741
Suzanne Hitchcock‐Bryan United States	8	242 1.1×	104 0.7×	555 3.8×	177 1.3×	322 2.8×	10	913
M. M. Oken United States	13	270 1.2×	159 1.1×	149 1.0×	147 1.1×	87 0.8×	19	734
Babak Bahar Iran	10	256 1.1×	62 0.4×	91 0.6×	182 1.4×	32 0.3×	37	438
Daniel M. Lane United States	15	134 0.6×	59 0.4×	298 2.0×	113 0.8×	244 2.2×	28	707
Ai‐Xuan L. Holterman United States	12	182 0.8×	120 0.8×	95 0.6×	250 1.9×	25 0.2×	18	867

Countries citing papers authored by Eveline de Bont

Since Specialization

Citations

This map shows the geographic impact of Eveline de Bont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eveline de Bont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eveline de Bont more than expected).

Fields of papers citing papers by Eveline de Bont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eveline de Bont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eveline de Bont. The network helps show where Eveline de Bont may publish in the future.

Co-authorship network of co-authors of Eveline de Bont

This figure shows the co-authorship network connecting the top 25 collaborators of Eveline de Bont. A scholar is included among the top collaborators of Eveline de Bont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eveline de Bont. Eveline de Bont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Meyran, Déborah, Arnaud Petit, Joëlle Guilhot, et al.. (2020). Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study. European Journal of Cancer. 137. 224–234. 7 indexed citations

Moerloose, Barbara De, Ardine Reedijk, Geertruida H. de Bock, et al.. (2019). Response‐guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML‐01. Pediatric Blood & Cancer. 66(5). e27605–e27605. 23 indexed citations

Millot, Frédéric, Joëlle Guilhot, Meinolf Suttorp, et al.. (2017). Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents. Haematologica. 102(10). 1704–1708. 38 indexed citations

Belderbos, Mirjam E., Sabrina Jacobs, Erik Zwart, et al.. (2017). Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding. Blood. 129(24). 3210–3220. 37 indexed citations

Millot, Frédéric, Joëlle Guilhot, Meinolf Suttorp, et al.. (2015). Switch to Subsequent Line of Treatment in Children and Adolescents with Chronic Myeloid Leukemia (CML) Treated with Imatinib: Experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents (I-CML-Ped Study). Blood. 126(23). 1576–1576. 1 indexed citations

Bont, Eveline de, Ardine Reedijk, Tim Lammens, et al.. (2015). Excellent Outcome in Pediatric AML with Response Guided Chemotherapy without Allogeneic HSCT in First Complete Remission: Results from Protocol DB-AML01. Blood. 126(23). 2506–2506. 5 indexed citations

Fuente, Josu de la, André Baruchel, Andrea Biondi, et al.. (2014). Managing children with chronic myeloid leukaemia (CML). British Journal of Haematology. 167(1). 33–47. 79 indexed citations

Bastelaar, James van, et al.. (2012). Densities in the left innominate vein after removal of an implantable venous device: a case report. Journal of Medical Case Reports. 6(1). 180–180. 8 indexed citations

Miedema, Karin G. E., Wim J. E. Tissing, Floor Abbink, et al.. (2012). RISK-ADAPTED APPROACH FOR FEVER AND NEUTROPENIA IN PEDIATRIC CANCER PATIENTS. Data Archiving and Networked Services (DANS). 59(6). 1007–1007. 1 indexed citations

10.

Bolt, Roel J., et al.. (2007). Encouraging outcome in pediatric oncology patients admitted to the intensive care unit. Pediatric Blood & Cancer. 49(4). 505–505. 294 indexed citations

11.

Graaf, S. de, et al.. (2002). Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: A mitochondrial controlled pathway regulated by reactive oxygen species?. International Journal of Oncology. 21(6). 1339–45. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact